Navigation Links
American Heart Association Announces Next New Journal - Circulation: Heart Failure Set for May Premier
Date:5/7/2008

News from Circulation: Heart Failure

DALLAS, May 7 /PRNewswire-USNewswire/ -- The American Heart Association has named the editor of Circulation: Heart Failure, its second of the planned six-publication extension to the weekly flagship journal, Circulation: Journal of the American Heart Association. The journals will be published by Lippincott Williams & Wilkins, a part of Wolters Kluwer Health.

James E. Udelson, M.D., acting chief of the division of cardiology at Tufts-New England Medical Center and associate professor of medicine and radiology at Tufts University School of Medicine, will serve as editor of Circulation: Heart Failure.

"Given the explosion of new information and knowledge in the heart failure field, the time seemed right for a journal devoted to exploring and highlighting many of those advances," said Udelson, who also is an associate editor for Circulation: Journal of the American Heart Association.

"At the manuscript review meetings for Circulation, we found ourselves commonly having to reject high-quality manuscripts simply on the basis of priority or because the work had a focus that was felt to be too highly specialized in nature," Udelson said. "It is our hope that Circulation: Heart Failure will provide a forum for continuing expansion of new knowledge that will ultimately increase our understanding of pathophysiology and translate into improved care for our patients."

"I am extremely pleased with the release of the second member of the Circulation portfolio of cardiovascular subspecialty journals, and with its new editor, Dr. Jim Udelson. With his strong leadership, this journal will rapidly become a major source of the latest information in the field of heart failure," said Joseph Loscalzo, M.D., Editor-in-Chief of Circulation and the Circulation subspecialty journal family.

Udelson says the new bi-monthly journal reflects the rapid growth and unfolding new directions in the field of heart failure. Circulation: Heart Failure will present high-quality, rigorously performed studies in clinical and translational science, as well as basic research articles with potential implications for the field. Recurring features will address the latest topics and controversies in heart failure, the development of new drugs and devices, and case reports and imaging studies of interest to clinicians involved in treating heart failure.

Circulation: Heart Failure is the second of the new Circulation portfolio of journals, designed to meet the growing demand for tightly focused information in areas at the cutting edge of cardiology. Circulation: Arrhythmia and Electrophysiology premiered recently. The remaining four titles -- Circulation: Cardiovascular Genetics; Circulation: Cardiovascular Imaging; Circulation: Cardiovascular Quality and Outcomes; and Circulation: Cardiovascular Interventions -- are scheduled for launch later in 2008.

Each issue of Circulation: Heart Failure and the other new journals will be available in both print and online formats. The journal Web site, http://circheartfailure.ahajournals.org, will launch next week when the first issue is posted and will also present "Publish Ahead of Print" articles and other online features.

American Heart Association/American Stroke Association Premium Professional members will have free, full-text access to journal articles through December 31, 2008. The first issue of each of the six new journals will be available to the public for free as sample issues.

About the American Heart Association

Founded in 1924, the American Heart Association is the nation's oldest and largest voluntary health organization dedicated to building healthier lives, free of heart disease and stroke. These diseases, America's No. 1 and No. 3 killers, claim more than 870,000 lives a year. In fiscal year 2006-07 the association invested more than $554 million in research, professional and public education, advocacy and community service programs to help all Americans live longer, healthier lives. To learn more, call 1-800-AHA-USA1 or visit americanheart.org.

About Wolters Kluwer Health

Wolters Kluwer Health (Conshohocken, PA), a division of Wolters Kluwer, is a leading provider of information and business intelligence for students, professionals and institutions in medicine, nursing, allied health, pharmacy and the pharmaceutical industry. Major brands include traditional publishers of medical and drug reference tools and textbooks, such as Lippincott Williams & Wilkins [www.LWW.com] and Facts & Comparisons(R); electronic information providers, such as Ovid, Medi-Span(R) and ProVation; and pharmaceutical information providers such as Adis International and Source(R). Wolters Kluwer Health has annual revenues (2007) of $1,044 million (euro 761 million) and employs approximately 2,700 employees globally. For more information, visit http://www.WKHealth.com.


'/>"/>
SOURCE American Heart Association
Copyright©2008 PR Newswire.
All rights reserved

Related medicine news :

1. Many Older Americans Have Active Sex Lives
2. Despite grumbling, most Americans say they are happy at work
3. Record Number of Americans Lack Health Insurance
4. Longaberger Expands Horizon of Hope Campaign to Build Support for American Cancer Societys Breast Cancer Initiatives
5. AUDIO from Medialink and Pfizer: Number of Uninsured Americans Grows to 47 Million
6. New Survey Shows Americans are Still Concerned About Food Safety, Yet Still Not Smart About What They Like to Eat
7. Novo Nordisk Appoints New Leader of North American Business
8. Amid Improving Life Expectancy Rates, Risk of Premature Death is Still Significant for Americans, New Study Shows
9. Primary biliary cirrhosis more severe in African-American and Hispanic patients
10. AOA President Calls on Congress to Reauthorize SCHIP and Take Action to Ensure Health Care Coverage for All Americans
11. American Chemical Societys Weekly Presspac -- Sept. 5, 2007
Post Your Comments:
*Name:
*Comment:
*Email:
(Date:5/27/2016)... ... 2016 , ... With over 60 percent of acute stroke survivors being left ... to aid in the rehabilitation process has steadily increased. Ekso Bionics had been working ... due to stroke. , Ekso Bionics has now received clearance from the U.S. Food ...
(Date:5/27/2016)... ... 27, 2016 , ... Beleza Medspa has initiated a new program ... is the first time that Coolsculpting is being used for for more than just ... ensure they meet the prescribed body-fat standard, measured by the circumference-based tape method. ...
(Date:5/27/2016)... ... 27, 2016 , ... With a team of certified experts, ... Aside from its GMP accreditation, Validation Center is also a registered authority of ... and staff. , Validation Center is ISO17025 accredited and only offers its clients ...
(Date:5/26/2016)... ... 26, 2016 , ... Cabot Corporation, Pfizer, and 3M are ... court documents and SEC filings. A jury has returned a verdict of ... Corporation, Case No. BC588866, Los Angeles County, California. The jury awarded $22.8 million ...
(Date:5/26/2016)... ... May 26, 2016 , ... On Memorial Day, Hope For Heroes ... in military battle for the country. The nonprofit Hope For Heroes partnered with ... that empower independence for disabled military veterans, as well as police, firemen, and EMS ...
Breaking Medicine News(10 mins):
(Date:5/26/2016)... , May 26, 2016   Change ... and analytics, network solutions and technology-enabled services ... it entered into a strategic channel partnership ... outpatient software solutions and revenue cycle management ... hospitals and rehabilitation clinics to optimize revenue, ...
(Date:5/25/2016)... HILDEN , Deutschland und GERMANTOWN, ... Zusammenarbeit mit Therawis bedient ... Entscheidungen bei Brustkrebs   QIAGEN N.V. ... QIA) gab heute bekannt, eine Lizenz- und Entwicklungsvereinbarung ... prädiktiver Assays für die Onkologie eingegangen zu sein. ...
(Date:5/25/2016)... According to market research "Global ... Demand Forecast to 2022 - Industry Insights by Type ... by P&S Market Research, the global insulin delivery device ... it is expected to grow at a CAGR of ... segment is expected to witness the fastest growth at ...
Breaking Medicine Technology: